TALLINN - Some experts believe that a number of modifications to Estonia’s laws on medicines and health insurance, and the inauguration of a new regulatory body, will alter the operation of the country’s pharmaceutical and healthcare companies in 2010. BMI believes that the use of generic drugs in Estonia is set to increase, following the introduction of a decree aimed at promoting the substitution of generics for prescription drugs.Building on current requirements for doctors to prescribe medicines by their international non-proprietary name (INN) rather than a brand na...
The article you requested can be accessed only by subscribing to the online version of The Baltic Times. If you are already subscribed to The Baltic Times, please authorize yourself.
In case you don't have a subscription yet - please visit our
SUBSCRIPTION section
